Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Royalty Pharma PLC (RPRX) had Free Cash Flow of $957.89M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$578.66M |
|
$30.18M |
|
-- |
|
$578.66M |
|
$368.87M |
|
$209.80M |
|
$-119.16M |
|
$90.64M |
|
$120.06M |
|
$90.64M |
|
$90.64M |
|
$90.64M |
|
$120.06M |
|
$209.80M |
|
$219.15M |
|
423.51M |
|
562.30M |
|
$0.07 |
|
$0.07 |
|
| Balance Sheet Financials | |
$1.52B |
|
$15.13B |
|
$16.80B |
|
$18.32B |
|
$1.21B |
|
$7.00B |
|
$7.61B |
|
$8.82B |
|
$9.50B |
|
$8.58B |
|
$9.50B |
|
992.25M |
|
| Cash Flow Statement Financials | |
$960.06M |
|
$191.94M |
|
$-1.45B |
|
$929.03M |
|
$631.91M |
|
$-297.12M |
|
$91.28M |
|
$-454.88M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.42 |
|
0.84 |
|
100.00% |
|
36.26% |
|
36.26% |
|
-- |
|
15.66% |
|
5.21% |
|
|
Free Cash Flow |
$957.89M |
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
20.86 |
|
4.31 |
|
0.95% |
|
1.06% |
|
0.49% |
|
0.55% |
|
$9.58 |
|
$1.70 |
|
$1.71 |
|